MicroRNA-34a: the bad guy in age-related vascular diseases

被引:63
|
作者
Raucci, Angela [1 ]
Macri, Federica [1 ]
Castiglione, Stefania [1 ]
Badi, Ileana [1 ,3 ]
Vinci, Maria Cristina [2 ]
Zuccolo, Estella [1 ]
机构
[1] Ctr Cardiol Monzino IRCCS, Expt Cardiooncol & Cardiovasc Aging Unit, Via C Parea 4, I-20138 Milan, Italy
[2] Ctr Cardiol Monzino IRCCS, Unit Vasc Biol & Regenerat Med, Milan, Italy
[3] Univ Oxford, Div Cardiovasc Med, Radcliffe Dept Med, Oxford, England
关键词
Senescence; Inflammaging; microRNA; Vascular calcification; Atherosclerosis; Diabetes; SMOOTH-MUSCLE-CELLS; CORONARY-ARTERY-DISEASE; MIR-34A EXPRESSION; TUMOR-SUPPRESSOR; REPLICATIVE SENESCENCE; PULMONARY-HYPERTENSION; ELEVATED MICRORNA-34A; EPIGENETIC REGULATION; DEPENDENT REGULATION; MONONUCLEAR-CELLS;
D O I
10.1007/s00018-021-03979-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The age-related vasculature alteration is the prominent risk factor for vascular diseases (VD), namely, atherosclerosis, abdominal aortic aneurysm, vascular calcification (VC) and pulmonary arterial hypertension (PAH). The chronic sterile low-grade inflammation state, alias inflammaging, characterizes elderly people and participates in VD development. MicroRNA34-a (miR-34a) is emerging as an important mediator of inflammaging and VD. miR-34a increases with aging in vessels and induces senescence and the acquisition of the senescence-associated secretory phenotype (SASP) in vascular smooth muscle (VSMCs) and endothelial (ECs) cells. Similarly, other VD risk factors, including dyslipidemia, hyperglycemia and hypertension, modify miR-34a expression to promote vascular senescence and inflammation. miR-34a upregulation causes endothelial dysfunction by affecting ECs nitric oxide bioavailability, adhesion molecules expression and inflammatory cells recruitment. miR-34a-induced senescence facilitates VSMCs osteoblastic switch and VC development in hyperphosphatemia conditions. Conversely, atherogenic and hypoxic stimuli downregulate miR-34a levels and promote VSMCs proliferation and migration during atherosclerosis and PAH. MiR34a genetic ablation or miR-34a inhibition by anti-miR-34a molecules in different experimental models of VD reduce vascular inflammation, senescence and apoptosis through sirtuin 1 Notch1, and B-cell lymphoma 2 modulation. Notably, pleiotropic drugs, like statins, liraglutide and metformin, affect miR-34a expression. Finally, human studies report that miR-34a levels associate to atherosclerosis and diabetes and correlate with inflammatory factors during aging. Herein, we comprehensively review the current knowledge about miR-34a-dependent molecular and cellular mechanisms activated by VD risk factors and highlight the diagnostic and therapeutic potential of modulating its expression in order to reduce inflammaging and VD burn and extend healthy lifespan.
引用
收藏
页码:7355 / 7378
页数:24
相关论文
共 50 条
  • [21] Recent Progress in Vascular Aging: Mechanisms and Its Role in Age-related Diseases
    Xu, Xianglai
    Wang, Brian
    Ren, Changhong
    Hu, Jiangnan
    Greenberg, David A.
    Chen, Tianxiang
    Xie, Liping
    Jin, Kunlin
    AGING AND DISEASE, 2017, 8 (04): : 486 - 505
  • [22] Age-related brainstem degeneration through microRNA modulation in mice
    Kawakita, Rie
    Takata, Tadayuki
    Nonaka, Wakako
    Hamada, Yasuhiro
    Iwama, Hisakazu
    Kobara, Hideki
    Deguchi, Kazushi
    Miyamoto, Osamu
    Nakamura, Takehiro
    Itano, Toshifumi
    Masaki, Tsutomu
    MOLECULAR MEDICINE REPORTS, 2023, 28 (02)
  • [23] Age-related vascular gene expression profiling in mice
    Rammos, Christos
    Hendgen-Cotta, Ulrike B.
    Deenen, Rene
    Pohl, Julia
    Stock, Pia
    Hinzmann, Christian
    Kelm, Matte
    Rassaf, Tienush
    MECHANISMS OF AGEING AND DEVELOPMENT, 2014, 135 : 15 - 23
  • [24] Perivascular adipose tissue in age-related vascular disease
    Queiroz, Marcelo
    Sena, Cristina M.
    AGEING RESEARCH REVIEWS, 2020, 59
  • [25] DNA Methylation Biomarkers in Aging and Age-Related Diseases
    Salameh, Yasmeen
    Bejaoui, Yosra
    El Hajj, Nady
    FRONTIERS IN GENETICS, 2020, 11
  • [26] Aging, frailty and age-related diseases
    T. Fulop
    A. Larbi
    J. M. Witkowski
    J. McElhaney
    M. Loeb
    A. Mitnitski
    G. Pawelec
    Biogerontology, 2010, 11 : 547 - 563
  • [27] Immune therapy for age-related diseases
    Weksler, Marc E.
    Pawelec, Graham
    Franceschi, Claudio
    TRENDS IN IMMUNOLOGY, 2009, 30 (07) : 344 - 350
  • [28] Aging, frailty and age-related diseases
    Fulop, T.
    Larbi, A.
    Witkowski, J. M.
    McElhaney, J.
    Loeb, M.
    Mitnitski, A.
    Pawelec, G.
    BIOGERONTOLOGY, 2010, 11 (05) : 547 - 563
  • [29] Telomere biology and age-related diseases
    Herrmann, Markus
    Pusceddu, Irene
    Marz, Winfried
    Herrmann, Wolfgang
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2018, 56 (08) : 1210 - 1222
  • [30] The integration of inflammaging in age-related diseases
    Fulop, Tamas
    Witkowski, Jacek M.
    Olivieri, Fabiola
    Larbie, Anis
    SEMINARS IN IMMUNOLOGY, 2018, 40 (0C) : 17 - 35